◐ Forecasted · RFA-RM-26-011
PRIMED-AI: Multi-use Framework Playbooks (UG3 Clinical Trial Not Allowed)
National Institutes of Health · HHS
CFDA Numbers
93.310
Award Ceiling
—
Award Floor
—
Expected Awards
—
Close Date
Jun 17, 2026
Section I
How to Apply
Program Contact
ODPRIMED-AI@od.nih.gov
301-402-3756
Section II
Eligibility
Eligible Applicant Types
00, 01, 05, 06, 07, 08, 11, 12, 20, 22, 23
Section III
Description
The NIH Common Fund, with other NIH Institutes and Centers (ICs), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Precision Medicine with Artificial Intelligence - Integrating Imaging with Multimodal Data (PRIMED-AI) program, which seeks to develop innovative, reliable, and cost-effective AI-based tools that integrate clinical imaging with other health data types to enhance personalized medicine for patients with chronic and other health conditions. The program’sPlaybook initiative will fund the development and initial testing of discrete projects that deliver “playbooks” of frameworks for responsible use of PRIMED-AI models, error mitigation and technical management of data and algorithms, data ontology/linkage, and preparation for regulatory approval (e.g., FDA). Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the UG3 activity code. Investigators with expertise and insights into AI-driven integration of clinical imaging with other complex and multiscale health data are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in harmonization processes for appropriate development and validation of multimodal AI tools to develop AI-based technologies leveraging multimodal data will be encouraged and these investigators should also begin considering applying for this application.
Section IV
Key Dates
- Posted
- Apr 17, 2026
- Closes
- Jun 17, 2026